publication date: Jul. 17, 2015
MD Anderson Faculty White Paper Calls for Executive Pay Freeze, Elimination of “Two-Class System”
MD Anderson Cancer Center’s faculty has asked the UT System to freeze the salaries of Ronald DePinho and members of his executive team until they reach a level of parity with faculty salaries, according to a white paper presented to UT System Chancellor Bill McRaven June 14.
The white paper—authored by the Executive Committee of the Faculty Senate and distributed confidentially to the faculty July 10—is arguably the most comprehensive representation of the faculty’s cumulative dissatisfaction with DePinho and his administration’s performance and handling of personnel matters over the past three years.
Iressa Returns to U.S. Market— Now with Companion Diagnostic
FDA approved Iressa (gefitinib) for patients with metastatic non-small cell lung cancer whose tumors have epidermal growth factor receptor exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test.
The drug is being approved concurrently with the therascreen EGFR RGQ PCR Kit as a companion diagnostic.
NCCS: Covering End-of-Life Planning is a Step Toward Delivering Patient-Centered Care
Last week, the Centers for Medicare & Medicaid Services announced plans to support Medicare beneficiaries by reimbursing doctors for advance care planning beginning in January 2016.
The proposed codes would reimburse for discussions about an individual’s wishes, should he or she becomes too ill to make decisions, and for the completion of an advance directive.
DoD Taking Applications for $75,000 Horizon Grant
The Department of Defense is taking applications for its Horizon Award, which offers up to $75,000 in funding to support junior-level scientists to conduct impactful research with the mentorship of an experienced cancer researcher.
The award is for principal investigators, both pre-doctoral candidates and postdoctoral fellows are eligible, and mentors that have a strong record of funding and publications. The PI and mentor must be from the same organization.
| ||In Brief|
Georgetown Lombardi and John Theurer Cancer Center to form research consortium
City of Hope establishes professorship with $1.5 million grant
Maryann Roefaro named co-chair of COA administrator network
Synexus opens three clinical trial research centers in Eastern Europe
ACT for NIH appoints seven members to its advisory committee
|Drugs and Targets|
EU approves Imbruvica in Waldenstrom’s macroglobulinemia
FDA grants orphan drug designation to ImMucin in multiple myeloma
Cleave Biosciences’s CB-5083 receives FDA orphan drug designation
FDA grants fast track designation to Toca 511 and Toca FC
FDA grants priority review to MM-398 in pancreatic cancer
Eli Lilly and Immunocore launch clinical trial collaboration